All Pathways
GastroenterologyEmergency

Acute Mesenteric Ischemia Management (ESVS 2017)

Acute Mesenteric Ischemia Management (ESVS 2017): Suspected Acute Mesenteric Ischemia → Clinical Recognition - High Index of Suspicion → Laboratory Stud...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Acute Mesenteric Ischemia

    Severe abdominal pain out of proportion to exam, especially with vascular/cardiac history

    1. Action

      Clinical Recognition - High Index of Suspicion

      Classic presentation often absent

      • Sudden severe abdominal pain (80%)
      • Pain out of proportion to physical exam
      • Risk factors: AF, recent MI, CHF, atherosclerosis, hypercoagulable
      • GI emptying (vomiting, diarrhea early)
      • Peritonitis = late sign (bowel necrosis)
      1. Action

        Laboratory Studies

        Supportive but not diagnostic

        • Lactate (elevated but non-specific)
        • D-dimer (elevated in most cases)
        • WBC (often elevated)
        • Metabolic acidosis (late)
        • Normal labs do NOT rule out AMI
        1. Decision

          AMI Subtype

          Determines treatment approach

          • Arterial embolism (~50%): AF, abrupt onset
          • Arterial thrombosis (~25%): atherosclerosis, subacute
          • MVT (~10%): hypercoagulable, portal HTN
          • NOMI (~15%): hypoperfusion, vasoconstrictors
          1. Action

            Immediate Resuscitation

            Start in parallel with workup

            • IV fluids - aggressive resuscitation
            • Correct acidosis/electrolytes
            • Broad-spectrum antibiotics
            • Anticoagulation (UFH) unless contraindicated
            • NG decompression
            • Avoid vasopressors if possible (worsen ischemia)
            1. Decision

              Signs of Bowel Necrosis/Peritonitis?

              Peritoneal signs, free air, pneumatosis

              1. Warning

                ⚠️ Emergent Laparotomy

                Necrotic bowel requires surgical resection

                • Resect non-viable bowel
                • Revascularization (embolectomy, bypass)
                • Second-look laparotomy at 24-48h
                • Damage control if unstable
                • Mortality 50-80%
                1. Action

                  Post-Treatment Care

                  ICU monitoring, nutrition, complications

                  • ICU monitoring
                  • Second-look surgery if needed
                  • Short bowel syndrome risk if extensive resection
                  • Long-term anticoagulation
                  • Address underlying cause (AF, hypercoagulable workup)
                  1. Outcome

                    Survival

                    Early diagnosis critical - overall mortality 50-80%

                  2. Outcome

                    Short Bowel Syndrome

                    If extensive resection required - may need long-term TPN

              2. Action

                Endovascular/Hybrid Approach

                If no peritonitis and viable bowel

                • Catheter-directed thrombolysis
                • Mechanical thrombectomy
                • Angioplasty + stenting
                • May combine with laparoscopy to assess bowel
                • Consider surgical backup
              3. Action

                MVT-Specific Treatment

                Anticoagulation is primary therapy

                • Systemic anticoagulation (UFH → LMWH/warfarin/DOAC)
                • Duration: 6+ months (often lifelong)
                • Catheter-directed thrombolysis if progressing
                • Surgery only if bowel necrosis
          2. Action

            NOMI Treatment

            Non-occlusive mesenteric ischemia

            • Treat underlying cause (shock, CHF)
            • Discontinue vasoconstrictors if possible
            • Intra-arterial papaverine/vasodilators
            • Optimize cardiac output
            • Surgery if bowel necrosis develops
      2. Action

        CT Angiography (CTA)

        Gold standard - obtain URGENTLY

        • Arterial + portal venous phase
        • Sensitivity/specificity >95%
        • Shows: SMA occlusion, bowel wall changes, pneumatosis
        • MVT: venous thrombus, bowel edema
        • Do NOT delay for other studies

Guideline Source

ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • High mortality rate even with treatment (50-80%)
  • Time-sensitive - requires rapid diagnosis
  • CT angiography is gold standard but interpretation requires expertise
  • Treatment approach depends on local surgical/IR expertise
  • NOMI treatment differs from occlusive disease

Applicable Regions

USEUGlobal

EU: ESVS 2017 is current standard

US: Similar management principles as European guidelines

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Acute Mesenteric Ischemia Management (ESVS 2017)?

The Acute Mesenteric Ischemia Management (ESVS 2017) is a emergency clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia.

What guideline is the Acute Mesenteric Ischemia Management (ESVS 2017) based on?

This algorithm is based on ESVS 2017 Clinical Practice Guidelines on the Management of Acute Mesenteric Ischaemia (DOI: 10.1016/j.ejvs.2017.01.010).

What are the limitations of the Acute Mesenteric Ischemia Management (ESVS 2017)?

Known limitations include: High mortality rate even with treatment (50-80%); Time-sensitive - requires rapid diagnosis; CT angiography is gold standard but interpretation requires expertise; Treatment approach depends on local surgical/IR expertise; NOMI treatment differs from occlusive disease. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Mesenteric Ischemia Management (ESVS 2017) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free